CRON has become an attractive play in the legalization of recreational cannabis. Taking a valuation call on the stock and the sector, shares now at $6.77, it can move to a level of $13.50 in next few months.
Seeks licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate.
Daily...saying this could almost double from 6.80...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.